Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

An investigational oral targeted therapy, zipalertinib (CLN-081), demonstrated meaningful tumor responses and a manageable ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

In a conversation with Managed Healthcare Executive, Michael Abrams, M.A., managing partner at Numerof & Associates, painted ...

The healthcare provisions include Medicaid work requirements and a broadening of the exemption to Medicare drug price negotiation ...

Health plans must embrace real-time member awareness, timely clinical context and actionable insights to realize the benefits ...

Climate change and air pollution are growing threats to public health, and new research suggests they may also worsen atopic ...

While the impact of Medicaid changes on employer-sponsored insurance remains to be seen, competition between providers is a ...

In an opinion article, investigators argue that gene therapies may not achieve their full potential if the innate inflammation in Duchenne muscular dystrophy is not effectively managed.

To prepare for CMS’ new risk adjustment data validation (RADV) strategy, Medicare Advantage plans must take a coordinated, ...